| Source HCPCS Code |
|
Target NDC Code |
J9153
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
|
⇄
|
68727-0745-01
VYXEOS 44 MG-100 MG VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9153
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
|
⇄
|
68727-0745-02
VYXEOS 44 MG-100 MG VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9153
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
|
⇄
|
68727-0745-05
VYXEOS 44 MG-100 MG VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2019 |
| Relationship End Date |
01/31/2023 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9153
Inj daunorubicin, cytarabine
|
⇄
|
68727-0745-02
Vyxeos
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9153
Inj daunorubicin, cytarabine
|
⇄
|
68727-0745-05
Vyxeos
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|